If enacted, SB165 would centralize the regulation of fentanyl analogues, making it illegal to possess, distribute, or manufacture any substance that falls under the defined categories without proper licensing or legal exemption. This could have profound implications for law enforcement at both state and federal levels, as it broadens the scope of prosecutable offenses related to drug use and distribution. It reflects a stronger stance against synthetic opioids, aiming to address the rising drug crisis more effectively.
Summary
SB165, known as the Stopping Overdoses of Fentanyl Analogues Act, proposes amendments to the Controlled Substances Act to classify fentanyl-related substances as Schedule I controlled substances. This change is intended to enhance federal control over variants of fentanyl, which have been associated with a significant rise in overdose deaths across the nation. The bill specifically defines 'fentanyl-related substances' as ones structurally related to fentanyl, encompassing any modifications that could alter its chemical properties while retaining similar effects.
Contention
While many advocates support the bill for its potential to combat opioid addiction and overdose crises, critics warn that it could lead to overreach in drug enforcement and unfair penalization of individuals unaware that they are in possession of regulated substances. There are concerns regarding the blanket classification of substance analogues which might hinder medical research and the availability of pain management options, particularly for patients who rely on these medications for legitimate medical needs.
Stopping Overdoses of Fentanyl Analogues ActThis bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires March 31, 2025.
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances.
Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substance.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25
Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25
Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25